affordable medicines
Minister ‘worried’ by US pricing policy
Government concerned about the implications Trump’s ‘most favoured nation’ policy could have for medicines access in Australia Pharmacists are being urged to engage in discussions about access to affordable medicines, …
‘Canberra policy bubble no fix for cost of living’
Interest rate relief is great, but it doesn’t touch the sides of the cost-of-living crisis… and if you’re renting, it’s unlikely to make much difference at all, writes Guild national …
Double dispensing delivering savings: Butler
Pharmacy organisation urged to “stand up” to “noisy opponents” of policies including 60-day dispensing Australian patients are reaping the benefits of 60-day prescriptions, Mark Butler the Minister for Health and …
Wesfarmers Health supports Federal Budget’s ‘cheaper medicine’ moves
Wesfarmers backs the government’s efforts to ease medicines costs for patients Australian Pharmaceutical Industries (API) owner Wesfarmers Health has welcomed measures in Tuesday’s Federal Budget aimed at making medicines more …
Only pharmacists opposed to double dispensing: MP
Opposition to 60-day dispensing appears to be restricted to pharmacists, Labor MP claims Excluding emails from pharmacists Labor backbencher, Graham Perrett, says there is “zero” opposition to the government’s 60-day …
‘We stood up to the Guild’ – Labor
Labor senator “really proud” of the government’s decision to pursue 60-day dispensing The government will not bow to the power of lobbyists, as it seeks to ease cost-of-living pressures, Labor’s …
Patient costs going in wrong direction: Guild
Guild calls for indexed increases to PBS co-payments to be dropped to ease cost of living pressures Annual increases to the Pharmaceutical Benefits Scheme (PBS) general and concessional co-payments are …
Cost remains a barrier to medicines
Increasing numbers of patients are delaying getting medicines or skipping scripts completely due to cost, Australian Bureau of Statistics (ABS) data reveals Cost barriers to accessing healthcare remain firmly in …
July MIMS update
We look at some of the recent changes to the medicines landscape, with new products, new indications, safety related changes and more New Products Finerenone (Kerendia) is a nonsteroidal antagonist …
Kiwis drop NZD$5 script copay
July change will cost AUD$580.6m over four years, says NZ health minister The New Zealand government will remove its NZD$5 (AUD$4.69) copayment for prescription medicines, the country’s health minister Ayesha …
Make medicines more affordable: Guild
Federal Treasurer, Jim Chalmers, is facing renewed calls to cut the Pharmaceutical Benefits Scheme (PBS) general co-payment for the second time in next month’s Budget Having successfully secured a $12.50 …
Fiasp de-listed from PBS
Diabetes patients are facing a significant increase in the cost of their medication following the government’s decision to remove Fiasp (insulin aspart injection) from the Pharmaceutical Benefits Scheme (PBS) Senator …